Two Sigma Advisers
LMAT icon

Two Sigma Advisers’s LeMaitre Vascular LMAT Stock Holding History

Two Sigma Advisers’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33,797
Closed -$2.74M – 1190
2025
Q4 		$2.74M Buy
33,797
+17,797
+111% +$1.53M 0.01% 1062
2025
Q3 		$1.4M Buy
16,000
+4,800
+43% +$429K ﹤0.01% 1297
2025
Q2 		$930K Buy
11,200
+4,400
+65% +$368K ﹤0.01% 1480
2025
Q1 		$571K Sell
6,800
-11,500
-63% -$1.07M ﹤0.01% 1721
2024
Q4 		$1.69M Sell
18,300
-7,200
-28% -$692K ﹤0.01% 1199
2024
Q3 		$2.37M Sell
25,500
-13,300
-34% -$1.15M 0.01% 989
2024
Q2 		$3.19M Sell
38,800
-23,500
-38% -$1.73M 0.01% 956
2024
Q1 		$4.13M Sell
62,300
-11,200
-15% -$691K 0.01% 854
2023
Q4 		$4.17M Sell
73,500
-8,300
-10% -$435K 0.01% 894
2023
Q3 		$4.46M Buy
81,800
+1,400
+2% +$83K 0.01% 796
2023
Q2 		$5.41M Buy
80,400
+14,000
+21% +$854K 0.01% 740
2023
Q1 		$3.42M Buy
66,400
+6,600
+11% +$320K 0.01% 988
2022
Q4 		$2.75M Sell
59,800
-3,600
-6% -$169K 0.01% 1063
2022
Q3 		$3.21M Sell
63,400
-1,600
-2% -$80K 0.01% 950
2022
Q2 		$2.96M Buy
65,000
+2,300
+4% +$103K 0.01% 1011
2022
Q1 		$2.91M Sell
62,700
-19,600
-24% -$877K 0.01% 1055
2021
Q4 		$4.13M Sell
82,300
-13,700
-14% -$708K 0.01% 851
2021
Q3 		$5.1M Sell
96,000
-400
-0.4% -$22.5K 0.01% 773
2021
Q2 		$5.88M Buy
96,400
+34,800
+56% +$1.85M 0.02% 790
2021
Q1 		$3M Buy
61,600
+53,000
+616% +$2.48M 0.01% 1073
2020
Q4 		$348K Buy
+8,600
New +$307K ﹤0.01% 1997
2020
Q1 		– Sell
-17,500
Closed -$629K – 2524
2019
Q4 		$629K Sell
17,500
-8,700
-33% -$300K ﹤0.01% 1774
2019
Q3 		$896K Hold
26,200
– – ﹤0.01% 1491
2019
Q2 		$733K Buy
26,200
+9,800
+60% +$272K ﹤0.01% 1660
2019
Q1 		$508K Buy
+16,400
New +$438K ﹤0.01% 1795
2018
Q4 		– Sell
-6,351
Closed -$246K – 2414
2018
Q3 		$246K Sell
6,351
-600
-9% -$21.6K ﹤0.01% 2018
2018
Q2 		$233K Buy
6,951
+100
+1% +$3.56K ﹤0.01% 2169
2018
Q1 		$248K Buy
+6,851
New +$237K ﹤0.01% 2077
2017
Q4 		– Sell
-73,651
Closed -$2.76M – 2321
2017
Q3 		$2.76M Sell
73,651
-12,800
-15% -$436K 0.01% 1053
2017
Q2 		$2.7M Sell
86,451
-3,600
-4% -$104K 0.01% 1050
2017
Q1 		$2.22M Buy
90,051
+7,598
+9% +$178K 0.01% 1202
2016
Q4 		$2.09M Buy
82,453
+9,753
+13% +$216K 0.01% 1156
2016
Q3 		$1.44M Buy
72,700
+37,600
+107% +$657K 0.01% 1179
2016
Q2 		$501K Buy
35,100
+14,300
+69% +$219K ﹤0.01% 1518
2016
Q1 		$323K Buy
20,800
+7,200
+53% +$103K ﹤0.01% 1636
2015
Q4 		$235K Buy
+13,600
New +$197K ﹤0.01% 1599

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Two Sigma Advisers's LMAT Position: Q1 2026 in Review

Two Sigma Advisers sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 33,797 shares — an estimated $2.74M sold.

Two Sigma Advisers first reported a position in LMAT in Q4 2015 and held it in 36 quarters. The position peaked at $5.88M in Q2 2021. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Two Sigma Advisers reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 33,797 LeMaitre Vascular shares in Q1 2026, an estimated $2.74M.
  • Two Sigma Advisers first reported a position in LeMaitre Vascular in Q4 2015 and held it in 36 quarters.
  • Two Sigma Advisers's LeMaitre Vascular position peaked at $5.88M in Q2 2021.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.